ArriVent BioPharma (AVBP) Treasury Shares (2023)
ArriVent BioPharma has reported Treasury Shares over the past 1 years, most recently at $7387.0 for Q4 2023.
- Quarterly results put Treasury Shares at $7387.0 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $7387.0 (changed N/A YoY), and the annual figure for FY2023 was $7387.0, changed.
- Treasury Shares reached $7387.0 in Q4 2023 per AVBP's latest filing, up from -$7387.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $7387.0 in Q4 2023 and bottomed at -$7387.0 in Q2 2023.